Literature DB >> 32238078

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel.

Manoj Kumar Gupta1, Sarojamma Vemula2, Ravindra Donde3, Gayatri Gouda3, Lambodar Behera3, Ramakrishna Vadde1.   

Abstract

Recent outbreak of Coronavirus disease (COVID-19) pandemic around the world is associated with 'severe acute respiratory syndrome' (SARS-CoV2) in humans. SARS-CoV2 is an enveloped virus and E proteins present in them are reported to form ion channels, which is mainly associated with pathogenesis. Thus, there is always a quest to inhibit these ion channels, which in turn may help in controlling diseases caused by SARS-CoV2 in humans. Considering this, in the present study, authors employed computational approaches for studying the structure as well as function of the human 'SARS-CoV2 E' protein as well as its interaction with various phytochemicals. Result obtained revealed that α-helix and loops present in this protein experience random movement under optimal condition, which in turn modulate ion channel activity; thereby aiding the pathogenesis caused via SARS-CoV2 in human and other vertebrates. However, after binding with Belachinal, Macaflavanone E, and Vibsanol B, the random motion of the human 'SARS-CoV2 E' protein gets reduced, this, in turn, inhibits the function of the 'SARS-CoV2 E' protein. It is pertinent to note that two amino acids, namely VAL25 and PHE26, play a key role while interacting with these three phytochemicals. As these three phytochemicals, namely, Belachinal, Macaflavanone E & Vibsanol B, have passed the ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) property as well as 'Lipinski's Rule of 5s', they may be utilized as drugs in controlling disease caused via SARS-COV2, after further investigation.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Coronaviruses; docking; modeling; molecular dynamics; severe acute respiratory syndrome

Year:  2020        PMID: 32238078      PMCID: PMC7171389          DOI: 10.1080/07391102.2020.1751300

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


Introduction

Coronaviruses (CoVs) are responsible for causing numerous diseases in broad ranges of vertebrates, including humans. Though earlier, CoVs were only associated with a common cold, for the first time in 2002, new CoVs related to the ‘severe acute respiratory syndrome’ (SARS-CoV) discovered in the human population of China and caused the death of 10% of the total cases worldwide (Perlman & Netland, 2009; Rota et al., 2003). Recently, in December 2019, numerous patients from Wuhan, China, reported regarding symptoms like pneumonia. However, initially it was identified as novel coronavirus, namely, 2019-nCoV. Later, the World Health Organization (WHO) renamed that virus as ‘severe acute respiratory syndrome coronavirus 2’ (SARS-CoV2) and the diseased caused by them is known as ‘coronavirus disease 2019’ (COVID-19). On March 11, 2020, the WHO officially declared the outbreak of COVID-19 as a pandemic (Ramphul & Mejias, 2020). On March 28, 2020, 614169 confirmed cases with 28239 deaths and 933 confirmed cases are reported in India with 20 deaths (https://mohfw.gov.in & WHO). Thus, there is an urgent requirement to understand the virulence mechanisms associated with these pathogens, which in turn permits the development of more effective remedies for early prevention as well as controlling future outbreaks. The SARS-CoV2 is an enveloped virus that belongs to the Coronaviridae family (Ramphul & Mejias, 2020). CoVs assemble together nearby intracellular membranes within the Endoplasmic reticulum-Golgi intermediate compartment (or ERGIC) after infection. Here they sprout within the lumen and consequently conveyed outside the cell through ‘exocytosis’ within the cargo vesicles (Krijnse-Locker et al., 1994; Tooze & Tooze, 1985). It is comprised of a positive-strand RNA genome of size 29.7 kb and encodes a viral replicase that is associated with the novel genome synthesis and generation of a ‘nested set of sub-genomic messenger RNAs, encoding both structural proteins present in all CoVs: Spike (S), Envelope (E), Membrane (M) and Nucleoprotein (N), and a group of proteins specific for SARS-CoV: 3a, 3b, 6, 7a, 7b, 8a, 8b, and 9b’(Nieto-Torres et al., 2014). While M and S protein constitutes the major portion of the viral envelope, E proteins are reported to oligomerize and form ion channels (Venkatagopalan et al., 2015). The E protein is located along with S-spike glycoprotein (Li et al., 2020), where it played a significant role in the assembly of the viral genome (Westerbeck & Machamer, 2019). SARS-CoV E’ protein’ is a short, integral membrane protein comprised of 76–109 amino acids and its size range from 8.4 to 12 kDa. It start a with short hydrophilic terminal followed by large hydrophobic transmembrane domain and terminates with long hydrophilic carboxyl end. Hydrophobic region oligomerise and form an ion-conductive pore in membranes. This protein play key role in various phases of the virus’ life cycle, such as envelope formation, pathogenesis, budding and assembly (Ashour et al., 2020; Schoeman & Fielding, 2019). Few studies have also suggested that the ‘SARS-CoV E’ proteins’ ion channel activity is modulated via pentameric ion channel (Pervushin et al., 2009). The ‘SARS-CoV E’ protein’s ion channel activity is detected in the transmembrane region of the protein (Verdiá-Báguena et al., 2012; Wilson et al., 2004). Selectivity, as well as ion conductance associated with the E protein ion channel, are mostly modulated via the lipid membranes charge within which the pores aggregates. This, in turn, supports that ‘lipid head-groups’ are the main component of the structure of the channel facing the pore’s lumen (Verdiá-Báguena et al., 2012, 2013). Though the involvement of ion channels in CoVs pathogenesis remains a topic of debate, recently several studies have suggested that the absence of ‘SARS-CoV E’ protein results in an ‘attenuated virus’, thereby supporting that ‘SARS-CoV E’ protein is mainly responsible for pathogenesis (Pervushin et al., 2009; Regla-Nava et al., 2015). The involvement of other proteins of SARS-CoV in pathogenesis remains unclear to date (Venkatagopalan et al., 2015). Few studies have also reported that mutations within the extra-membrane domain of ‘SARS-CoV E’ protein disrupt the normal viral assembly as well as maturation (Fischer et al., 1998; Torres et al., 2007; Verdiá-Báguena et al., 2012). In transmissible gastroenteritis virus, the ‘SARS-CoV E’ protein deletion led to virus trafficking blockage within the secretory pathway as well as virus maturation (Curtis et al., 2002). Thus, the ‘SARS-CoV E’ protein server as a key biomarker for preventing pathogenesis associated with the SARS-CoV (Pervushin et al., 2009). For gaining detail insight into the structure & function, to date numerous ‘three-dimensional’ structures of the ‘SARS-CoV E’ protein have been deposited in the ‘Protein Data Bank (PDB)’. Furthermore, as identifying novel drugs through laboratory approaches demands huge capital as well as investments, there is a continuous demand for screening drug molecules via high screeening computational methods that saves both money as well as times (Gupta, Donde, et al., 2019; Gupta & Vadde, 2020b; Gupta & Vadde, 2020a). Nevertheless, ADMET (‘Absorption, Distribution, Metabolism, Excretion and Toxicity’) as well as ‘Lipinski’s Rule of 5s’ property passed natural drugs may have either minimum or no adverse-effects (Gupta et al., 2020; Gupta & Vadde, 2020a,b). Recently, genome of the first SARS-CoV2 (Wuhan-Hu-1) has also been successfully sequenced and submitted in GenBank (Accession no. MN908947.3) (Shang et al., 2020). By considering the above information, in the present study, authors employed computational approach for identifying the best possible structure of the ‘SARS-CoV2 E’ protein present in the PDB database to understand its structure and function as well as its behaviour towards various phytochemicals. This, in turn, may help us in identifying few phytochemicals that may inhibit the function of the ‘SARS-CoV2 E’ protein; thereby preventing the pathogenesis associated with SARS-CoV2. In the near future, these phytochemicals may serve as a good contestants for treating diseases caused by SARS-CoV2 after further laboratory investigation.

Methodology

Sequence and structure download

The Uniprot was utilized for downloading the humanSARS-CoV E’ protein sequence (ID: P59637). The NCBI protein database was utilized for downloading the humanSARS-CoV2 E’ protein sequence (ID: YP_009724392.1). Multalin, a web-based tool was implemented to detect difference between ‘SARS-CoV E’ and ‘SARS-CoV2 E’ protein. Subseqeuntly, sequence of ‘SARS-CoV2 E’ protein was subjected to NCBI’s utility ‘BLASTp’ (Altschul et al., 1990). Based on maximum sequence identity (81%), structure with PDB (Protein Data Bank) ID 5 × 29 is detected as the best homologous structure of humanSARS-CoV2 E’ protein. As the ‘SARS-CoV E’ protein function as a homopentamer (Pervushin et al., 2009), the complete structure of 5 × 29, comprised of five chains, was employed for downstream analysis.

Molecular dynamic simulations (MDS): Phase I

To gain detail insight into the structural characteristic of the downloaded protein and removing any conflicts present between its atoms of main and side chain (Donde et al., 2019; Gouda et al., 2020; Gupta & Vadde, 2020b), MDS were employed using ‘Gromos96-43a1 force field’ of ‘GROMACS 5.1’ for 200 ns (Abraham et al., 2015). As ‘SARS-CoV2 E’ protein resides is a transmembrane region, at first, downloaded structure of 5 × 29 was embedded in the ‘equilibrated bilayer of DPPC (dipalmitoylphosphatidylcholine)’ using ‘g_membed’ tool of ‘GROMACS 5.1’ (Wolf et al., 2010) using the aid of ‘Berger lipids’ derived parameters from ‘Berger, Edholm, and Jahnig’ (Berger et al., 1997). Further solvation of the entire system till energy minimization followed by equilibrating the complete system under NVT (‘Constant Number of Particles, Pressure and Temperature’) and NPT (‘Constant Number of Particles, Volume, and Temperature’) conditions were carried out as stated in detail at http://www.mdtutorials.com/gmx/membrane_protein/index.html. Final molecular dynamic (MD) trajectories as well as the quality of simulations were analyzed via ‘GROMACS 5.1’ (Gupta & Vadde, 2020b). ‘Principal Component Analysis’ (PCA) was also carried out for capturing the most flexible area and the motion of the α-helix & the β-strands present within the protein during 200 ns. Equilibrated conformers from the MD were used to produce the mean structure of the ‘SARS-CoV2 E’ protein (Gupta & Vadde, 2020b). Backbone atoms’ free energy for the ‘SARS-CoV2 E’ protein was calculated using the ‘GROMACS 5.1’ from 20 ns to 200 ns with 20 ns interval (Gupta & Vadde, 2020b).

Preparation of ligands

‘Three-dimensional’ structure of 4153 phytochemicals having ‘drug-like’ features from our earlier published literatures (Gupta & Vadde, 2019a, 2020a,b) were employed in the present study. The DrugMint server The DrugMint server (Dhanda et al., 2013) was employed for detecting ADMET or ‘drug-like’ properties of each phytochemicals. DrugMint server predicts ADMET or drug-likelihood of any drug/phytochemicals using various classification models. All models were trained, tested and evaluated on a dataset comprised of 3206 experimental drugs and 1347 approved drugs of DrugBank 2.5. All QSAR models were developed using open source software packages like PaDEL, WEKA, SVM_Light (Dhanda et al., 2013) ‘Three-dimensional’ structures of each phytochemicals were obtained from TIPdb database and have either anti-tuberculosis, anti-cancer, anti-platelet, or no therapeutic properties (Lin et al., 2013).

Molecular docking

The active site pocket present in the ‘SARS-CoV2 E’ protein was calculated using the CASTp server (Binkowski et al., 2003). Active pocket with the highest volume as well as area was considered for molecular docking studies with phytochemicals having 250 conformations (Gupta, Vadde, et al., 2019; Gupta & Vadde, 2020b) via the AutoDock (Morris et al., 2009) tool. Three best phytochemical having the minimal binding energy was considered for further study (Gupta & Vadde, 2020b). Complex formation was done employing the ‘Discovery Studio’ Software (Biovia, 2017).

MDS: Phase II

Amongst 250 conformations, the docking result of the ‘SARS-CoV2 E’ protein with three different phytochemicals having the minimal binding energy was considered for the 200 ns MDS, separately (Gupta & Vadde, 2020). The PRODRG server (Schüttelkopf & van Aalten, 2004) was employed for generating the ligand’s topology parameters. Subsequently, complete MDS was performed as described above in the MDS: Phase I.

MM/PBSA calculations

Using the GMXAPBS utility of the ‘GROMAC 5.1’, 2000 snapshots were retrieved from the MD trajectories of all the three complexes, individually, to calculate the binding free energy from 20 to 200 ns with 20 ns interval (Gupta & Vadde, 2020b).

Inter-molecular interaction studies

Inter-molecular interactions present within the three complexes after 200 ns MDS were performed via Discovery Studio (Gupta & Vadde, 2020b).

Results and discussion

Protein model

Comparative sequence analysis via Multalin reveals that ‘SARS-CoV E’ and ‘SARS-CoV2 E’ protein sequence share 94.74% identity amongst themselves. The ‘three-dimensional’ structure of one unit of ‘SARS-CoV2 E’ comprised of only seven α-helices and eight loops (Figure 1(a)). As there are five homo-units, the complete structure of ‘SARS-CoV2 E’ consists of 35 α-helices and 40 loops (Figure 1(b)). As the ‘SARS-CoV E’ proteins’ ion channel activity is modulated via pentameric ion channel (Pervushin et al., 2009), complete structure comprising of five subunits was employed for the downstream analysis.
Figure 1.

(a) Sequence similarity between protein sequence of ‘SARS-CoV E’ and ‘SARS-CoV2 E’ protein. 3D structure of ‘SARS-CoV2 E’ protein, (b) One unit is composed of only seven α-helices and 8 loops. (c) Homopentamer. In (c), green, pink, orange, blue and cyan depicts chain A, B, C, D and E of the ‘SARS-CoV2 E’ pentameric protein.

(a) Sequence similarity between protein sequence of ‘SARS-CoV E’ and ‘SARS-CoV2 E’ protein. 3D structure of ‘SARS-CoV2 E’ protein, (b) One unit is composed of only seven α-helices and 8 loops. (c) Homopentamer. In (c), green, pink, orange, blue and cyan depicts chain A, B, C, D and E of the ‘SARS-CoV2 E’ pentameric protein.

MDS: Phase I

To understand the structural characteristics of the ‘SARS-CoV2 E’ protein, MD trajectories of 200 ns were analyzed (Gupta & Vadde, 2020b). The obtained result revealed that during 200 ns, potential energy fluctuates within −2785852.25 & −1717123.84 kJ/mol. Pressure fluctuates within −311.56 bar & 338.38 bar with an average value 1.75 bar. The temperature fluctuates within 296.97 K & 303.30 K with an average value of 299.99 K. Density fluctuates within 973.57 & 991.84 kg/m3 with an average value 980.78 kg/m3. Root mean square deviation (RMSD) & root mean square fluctuation (RMSF) of Cα atoms as a function of residue number and radius of gyration (Rg) as a function of simulation time (Donde et al., 2019; Gouda et al., 2020; Gupta et al., 2018; Mehrnejad & Chaparzadeh, 2008; Rani & Lakshmi, 2019; Tandon et al., 2015) were employed for estimating the protein stability during the MD analysis. The average RMSD value of the protein backbone atoms is estimated to be 2.74 Å (Figure 2(a)). RMSD is found to be stable subsequently 170 ns. The value of RMSF fluctuates within 4 Å & 6.3 Å with an average value of 5.96 Å. Amino acids that undergo maximum fluctuation during 200 ns MDS were VAL17, ALA22, LEU19, LEU27, PHE23, PHE26, LEU27, VAL24, VAL25, VAL29, ILE33, ALA36 and TYR42 (i.e. RMSF > 6 nm). As these residues play an important role during protein-ligand interaction, they may serve as a biomarker during the drug discovery process (Gouda et al., 2020; Gupta & Vadde, 2019a, 2020a, 2020b) (Figure 2(b)). The Rg values of the protein (Figure 2(c)), fluctuates within 5.81 Å & 5.83 Å with an average value of 5.82 Å; thereby supporting its condensed architecture as well as size (Donde et al., 2019; Gupta & Vadde, 2019b). Result obtained from the PCA analysis suggests the random movement of the ‘SARS-CoV2 E’ protein (Figure 2(d)) throughout the 200 ns MDS. Mean number of ‘intra-protein’ hydrogen bond & ‘inter-hydrogen’ bond formed between ‘SARS-CoV2 E’ protein & water is 1.98 and 1.98, respectively. ‘Cross-correlation matrix’ of the C-α displacement revealed that all residues present within the ‘SARS-CoV2 E’ protein experience both negative (depicted via blue shades) as well as positive correlated motions (depicted via red shades) (Figure 3(a)), which in turn support random movement of the ‘SARS-CoV2 E’ protein. This finding is also in accordance with the ‘free energy landscape’ analysis (Figure 4(a)). Minimal energy associated with the FEL for the ‘SARS-CoV2 E’ protein at 20 to 200 ns with difference of 20 ns are 0.20, 0.28, 0.32, 0.38, 0.41, 0.41, 0.43, 0.43, 0.45 and 0.49 kcal/mol respectively.
Figure 2.

The stability parameters for ‘SARS-CoV E’ protein during 200 ns: (a) RMSD of C-α (b) RMSF of C-α (c) Radius of gyration of C-α, and (d) Principle Component Analysis (PCA) of α-helix and β-strand movement. The trajectory projected to the two-dimensional space. Black, light green, blue, and orange lines represent ‘SARS-CoV2 E’ protein and Complexes A, B & C during 200 ns, respectively.

Figure 3.

Comparative study of cross-correlation matrices of C-α atoms of modeled (a) ‘SARS-CoV2 E’ protein (b) Complex A (c) Complex B and (d) Complex C during 200 ns simulation. The range of motion indicated by various colors in the panel. Red indicates a positive correlation, whereas blue indicates anti-correlation.

Figure 4.

Projections of the free energy landscape of (a) ‘SARS-CoV2 E’ protein (b) Complex A (c) Complex B and (d) Complex C during 200 ns simulation. Various colors in the panel indicate the range of motion, where dark black indicates the lowest energy configuration, and white shows the highest energy configuration.

The stability parameters for ‘SARS-CoV E’ protein during 200 ns: (a) RMSD of C-α (b) RMSF of C-α (c) Radius of gyration of C-α, and (d) Principle Component Analysis (PCA) of α-helix and β-strand movement. The trajectory projected to the two-dimensional space. Black, light green, blue, and orange lines represent ‘SARS-CoV2 E’ protein and Complexes A, B & C during 200 ns, respectively. Comparative study of cross-correlation matrices of C-α atoms of modeled (a) ‘SARS-CoV2 E’ protein (b) Complex A (c) Complex B and (d) Complex C during 200 ns simulation. The range of motion indicated by various colors in the panel. Red indicates a positive correlation, whereas blue indicates anti-correlation. Projections of the free energy landscape of (a) ‘SARS-CoV2 E’ protein (b) Complex A (c) Complex B and (d) Complex C during 200 ns simulation. Various colors in the panel indicate the range of motion, where dark black indicates the lowest energy configuration, and white shows the highest energy configuration. The random movement of the ‘SARS-CoV2 E’ protein indicates its involvement in the ion channels. This is in accordance with earlier studies where authors have reported that the ion channel activity of ‘SARS-CoV2 E’ proteins is modulated via pentameric ion channel (Pervushin et al., 2009). It is pertinent to note that the structure of ‘SARS-CoV2 E’ protein becomes stable after 170 ns. Hence, the average structure of the ‘SARS-CoV2 E’ protein was obtained from the stable plateau of the RMSD after 170 ns for downstream analysis.

Molecular docking with phytochemicals

Further, the CASTp server was employed for detecting the active site present within the ‘SARS-CoV2 E’ protein. The obtained result revealed that the highest volume and area of the binding cavity within the ‘SARS-CoV2 E’ protein is 7625.969 Å3 & 7163.067 Å2, respectively. Forty-four amino acids that are involved in the formation of the active site are GLU8, THR11, LEU12, VAL14, ASN15, VAL17, LEU18, LEU19, PHE20, LEU21, ALA22, PHE23, VAL24, VAL25, PHE26, LEU27, LEU28, VAL29, THR30, LEU31, ALA32, ILE33, LEU34, THR35, ALA36, LEU37, ARG38, LEU39, ALA40, TYR42, ALA43, ALA44, ILE46, VAL47, VAL49, LEU51, PRO54, VAL56, TYR57, SER60, ARG61, LYS63, ASN64 and LEU65. Subsequently, molecular docking between the protein and ligand with 250 conformations was performed using the AutoDock tool. 126 × 126 X 126 was assigned as a grid box with a grid center of −0.496, 0.0 and 0.0. The grids were selected very carefully for allocating active sites along with the surrounding surface’s major area (Donde et al., 2019; Gouda et al., 2020; Gupta, Vadde, et al., 2019). Subsequently, molecular docking of the ‘SARS-CoV2 E’ protein with ligands having 250 conformations using the AutoDock tool revealed that the best ten phytochemicals with minimal binding energy are TIP006452 (Belachinal), TIP005365 (Macaflavanone E), TIP003272 (Vibsanol B), TIP003258 (14 R*,15-Epoxyvibsanin C), TIP005363 (Macaflavanone C), TIP000749 (Luzonoid D), TIP008605 (Grossamide K), TIP009461 ((-)-Blestriarene C), TIP005366 (Macaflavanone F) and TIP005783 (Dolichosterone). Binding energy of ‘SARS-CoV2 E’ protein with TIP006452, TIP005365, TIP003272, TIP003258, TIP005363, TIP000749, TIP008605, TIP009461, TIP005367, TIP005366 and TIP005783 is −11.46 kcal/mol, −11.07 kcal/mol, −11.07 kcal/mol, −10.56 kcal/mol, −10.49 kcal/mol, −10.47 kcal/mol, −10.50 kcal/mol, −10.40 kcal/mol, −10.40 kcal/mol, −10.36 kcal/mol and −10.31 kcal/mol, respectively (Supplementary File I and Table 1). Binding energy of all 4153 phytochemicals is depicted in the Supplementary File I. Earlier one study has reported that Macaflavanone C may be utilized for treating Alzheimer’s disease (Gupta & Vadde, 2019a). In 2016, Teponno and the team reported about the anti-melanogenic property of the Grossamide K (Bertrand Teponno et al., 2016). Earlier Seo and his team have also reported that compounds present in the ethyl acetate fraction of Sanguisorba officinalis, namely euphormisin M3, arjunglucoside II, pomolic acid‐3‐β‐O‐α‐L‐arabionopyranoside, 3,3′‐di‐O‐methylellagic acid, 3,8‐dihydroxy‐4,10‐dimethoxy‐7‐oxo‐[2] benzopyrono [4,3‐b][1]benzopyran‐7‐(5H)‐one, chikusetsusaponin II, deglucose chikusetsusaponin Iva, belachinal, irilone and ellagic acid, may have the inhibitory effect on inflammasome pathways and protective role in endotoxin‐induced septic shock. However, to best of our knowledge, no medicinal properties have been assigned to rest seven phytochemicals, namely, Macaflavanone E, Vibsanol B, ‘14 R*,15-Epoxyvibsanin C’, Luzonoid D, (-)-Blestriarene C, Macaflavanone F and Dolichosterone. As three compounds, namely, Belachinal, Macaflavanone E and Vibsanol B, have the minimal binding energy with the ‘SARS-CoV2 E’ protein (Table 1), three separate complexes between ‘SARS-CoV2 E’ protein and each ligand were done separately using Discovery Studio Software. The complex of the ‘SARS-CoV2 E’ protein with Belachinal, Macaflavanone E and Vibsanol B, separately, will be known as Complex A, B and C, respectively, henceforth.
Table 1.

Free binding energy (Kcal/mol) scores of the best ten interacting phytochemicals with ‘SARS-CoV2 E’ protein.

IDPhytochemicalPlant sourceInhibition constantvdW + H bond +  desolv Energy (kcal/mol)Final total internal energy (kcal/mol)Torsional free energy (kcal/mol)Final intermolecular energy (kcal/mol)Electrostatic energy (kcal/mol)Free energy of binding (kcal/mol)Unbound system's energy (kcal/mol)
TIP006452BelachinalBelamcanda chinensis3.99 nM (nanomolar)−12.37−2.490.89−12.350.02−11.46−2.49
TIP005365Macaflavanone EMacaranga tanarius7.71 nM (nanomolar)−12.01−1.420.89−11.960.05−11.07−1.42
TIP003272Vibsanol BViburnum odoratissimum7.62 nM (nanomolar)−11.92−1.530.89−11.97−0.05−11.07−1.53
TIP00325814R*,15-Epoxyvibsanin CViburnum odoratissimum18.24 nM (nanomolar)−11.46−2.040.89−11.450.01−10.56−2.04
TIP005363Macaflavanone CMacaranga tanarius20.45 nM (nanomolar)−11.34−1.560.89−11.38−0.04−10.49−1.56
TIP000749Luzonoid DViburnum luzonicum21.26 nM (nanomolar)−11.39−2.140.89−11.360.02−10.47−2.14
TIP008605Grossamide KHibiscus cannabinus20.01 nM (nanomolar)−11.33−2.050.89−11.4−0.07−10.50−2.05
TIP009461(-)-Blestriarene CCremastra appendiculata23.82 nM (nanomolar)−11.27−1.770.89−11.29−0.02−10.40−1.77
TIP005366Macaflavanone FMacaranga tanarius25.33 nM (nanomolar)−11.24−1.450.89−11.26−0.02−10.36−1.45
TIP005783DolichosteroneOryza sativa and Zea mays27.52 nM (nanomolar)−11.19−1.460.89−11.21−0.02−10.31−1.46
Free binding energy (Kcal/mol) scores of the best ten interacting phytochemicals with ‘SARS-CoV2 E’ protein. For gaining detail insight into the structural characteristics of Complex A to C separately, MD trajectories of each three complexes for 200 ns were analyzed separately through ‘GROMACS5.1’. The obtained result revealed that during 200 ns, in Complex A potential energy fluctuates within −4305011.50 & −3247362.33 kJ/mol. Pressure fluctuates within −397.76 bar & 379.10 bar with an average value 2.74 bar. Density fluctuates within 986.89 & 1000.63 kg/m3 with an average value 993.64 kg/m3. In Complex B, potential energy fluctuates within −3524890.12 & −2435552.00 kJ/mol. Pressure fluctuates within −369.94 bar & 349.67 bar with an average value 2.32 bar. Density fluctuates within 982.12 & 999.99 kg/m3 with an average value 986.74 kg/m3. In Complex C, potential energy fluctuates within −3311430.25 & −2095840.00 kJ/mol. Pressure fluctuates within −349.38 bar & 376.10 bar with an average value 2.15 bar. Density fluctuates within 979.40 & 995.38 kg/m3 with an average value 982.81 kg/m3. In all three complexes, the temperature fluctuates within ∼295.24 K & ∼304.98 K with an average value of 300.00 K. Average RMSD value of the protein backbone atoms in Complex A-C is estimated to be 1.75 Å, 2.16 Å and 2.56 Å, respectively (Figure 2(a)). RMSD in all the three complexes is found to be stable subsequently 180 ns. The Rg values of all three complexes (Figure 2(c)) support their condensed architecture as well as size (Gupta & Vadde, 2020). Minimal energy associated with the FEL for the Complex A at 20 to 200 ns with difference of 20 ns are 0.26, 0.36, 0.25, 0.31, 0.35, 0.37, 0.40, 0.42, 0.42, 0.43, 0.44 & 0.44 kcal/mol respectively. Minimal energy associated with the FEL for the Complex B at 20 to 200 ns with difference of 20 ns are 0.26, 0.31, 0.31, 0.37, 0.38, 0.40, 0.41, 0.43, 0.45 & 0.45 kcal/mol respectively. Minimal energy associated with the FEL for the Complex C at 20 to 200 ns with difference of 20 ns are 0.26, 0.36, 0.37, 0.39, 0.40, 0.41, 0.42, 0.42, 0.44 & 0.47 kcal/mol, respectively. Result obtained from the PCA analysis suggests that the movement of Complex A < Complex B < Complex C< ‘SARS-CoV2 E’ protein (Figure 2(d)). This might be due to decreased potential energy and increased pressure in all the three complexes, which in turn supports that the random movement of the ‘SARS-CoV2 E’ protein decrease after binding with these phytochemicals (Figure 2(d)); thereby supporting that these three phytochemicals may function as drugs for treating or controlling diseases caused via SARS-CoV2 in human.

MM/PBSA calculations for ligand binding affinities

The obtained result revealed that the final binding energy of Complex A (−250.979 ± 0.272 kJ/mol) SASA (Solvent Accessible Surface Areas), van der Waal, polar solvation, and final, binding energy from 20 ns to 200 ns with 20 ns interval of Complex A to C complexes are depicted in Table 2.
Table 2.

Final binding energy (kJ/mol) between protein and phytochemicals, obtained through MM/PBSA estimation, in Complex AC from 20 to 200 ns with 20 ns interval.

ComplexTime (ns)van der Waal energy (kJ/mol)SASA energy (kJ/mol)Binding energy (kJ/mol)Electrostattic energy (kJ/mol)Polar solvation energy (kJ/mol)
Complex A20−232.399 ± 2.692−20.992 ± 0.209−208.518 ± 2.314−49.745 ± 0.55094.580 ± 1.079
40−250.391 ± 1.490−22.075 ± 0.114−225.224 ± 1.310−51.492 ± 0.31498.747 ± 0.575
60−258.354 ± 1.064−22.744 ± 0.081−232.717 ± 0.940−53.110 ± 0.231101.502 ± 0.402
80−262.304 ± 0.831−23.106 ± 0.064−236.226 ± 0.733−54.292 ± 0.190103.475 ± 0.324
100−266.681 ± 0.679−23.450 ± 0.053−239.571 ± 0.612−54.877 ± 0.167105.424 ± 0.284
120−269.779 ± 0.617−23.693 ± 0.047−242.226 ± 0.542−55.629 ± 0.152106.884 ± 0.244
140−270.669 ± 0.513−23.759 ± 0.041−243.042 ± 0.466−56.199 ± 0.132107.598 ± 0.218
160−276.545 ± 0.377−24.012 ± 0.027−245.952 ± 0.311−56.694 ± 0.089111.303 ± 0.178
180−281.613 ± 0.517−24.198 ± 0.035−248.422 ± 0.405−57.253 ± 0.119114.619 ± 0.268
200−286.018 ± 0.355−24.385 ± 0.023−250.979 ± 0.272−57.657 ± 0.080117.087 ± 0.186
Complex B20−194.989 ± 1.504−18.758 ± 0.149−169.711 ± 1.457−14.672 ± 0.39258.713 ± 0.751
40−204.767 ± 0.906−19.490 ± 0.083−181.077 ± 0.887−15.313 ± 0.23758.485 ± 0.464
60−212.452 ± 0.729−20.226 ± 0.067−186.884 ± 0.680−16.890 ± 0.19062.672 ± 0.437
80−222.140 ± 0.694−20.890 ± 0.058−194.731 ± 0.633−17.348 ± 0.15165.650 ± 0.378
100−231.827 ± 0.709−21.409 ± 0.052−201.292 ± 0.595−18.737 ± 0.14370.692 ± 0.383
120−240.733 ± 0.704−21.884 ± 0.049−207.375 ± 0.553−19.845 ± 0.13375.075 ± 0.375
140−245.532 ± 0.650−22.073 ± 0.044−211.410 ± 0.517−20.433 ± 0.12376.615 ± 0.337
160−246.434 ± 0.406−22.105 ± 0.027−212.651 ± 0.332−20.695 ± 0.07976.567 ± 0.214
180−246.422 ± 0.524−22.060 ± 0.036−212.942 ± 0.429−20.864 ± 0.10376.387 ± 0.276
200−248.494 ± 0.343−22.219 ± 0.024−214.938 ± 0.280−21.055 ± 0.06576.820 ± 0.178
Complex C20−254.979 ± 2.304−22.542 ± 0.125−239.349 ± 2.1103.371 ± 0.23134.849 ± 0.706
40−286.216 ± 1.576−24.151 ± 0.086−248.460 ± 1.145−3.150 ± 0.30165.013 ± 1.248
60−303.324 ± 1.269−25.038 ± 0.067−251.388 ± 0.815−7.891 ± 0.27584.866 ± 1.122
80−313.068 ± 1.029−25.344 ± 0.053−253.574 ± 0.625−10.362 ± 0.23195.204 ± 0.929
100−322.209 ± 0.905−25.579 ± 0.045−256.632 ± 0.533−11.477 ± 0.193102.636 ± 0.812
120−317.991 ± 1.281−24.957 ± 0.088−249.991 ± 0.943−11.753 ± 0.171104.741 ± 0.771
140−301.108 ± 1.711−23.549 ± 0.128−234.943 ± 1.447−11.302 ± 0.150101.072 ± 0.740
160−267.273 ± 1.495−20.882 ± 0.116−207.250 ± 1.261−10.046 ± 0.10490.990 ± 0.576
180−261.003 ± 2.103−20.275 ± 0.163−202.484 ± 1.800−9.884 ± 0.13688.642 ± 0.777
200−254.047 ± 1.497−19.626 ± 0.114−197.457 ± 1.236−9.794 ± 0.09186.053 ± 0.539
Final binding energy (kJ/mol) between protein and phytochemicals, obtained through MM/PBSA estimation, in Complex AC from 20 to 200 ns with 20 ns interval.

Intermolecular interaction studies

Intermolecular interaction study in all the three complexes, separately, via Discovery Studio, suggests that amino acid involved in the intermolecular interaction of Complex A with ligands, are LEU19, ALA22, PHE23, VAL25, PHE26 and VAL29. Ten hydrophobic bonds C:ALA22 -: TIP006452:C, D:ALA22 -: TIP006452:C,: TIP006452:C - C:LEU19,: TIP006452:C - D:VAL25,: TIP006452:C - D:VAL29,: TIP006452:C - D:VAL29,: TIP006452:C - D:VAL29, C:PHE23 -: TIP006452:C, C:PHE26 -: TIP006452:C and D:PHE26 -: TIP006452:C) are formed. Hydrophobic bond length ranges from 4.30 Å to 5.90 Å (Figure 5(a)). Amino acid involved in the intermolecular interaction of Complex B with ligands, are PHE23, VAL24, VAL25, PHE26, LEU27 and LEU65. Fourteen hydrophobic bonds (C:PHE23 -: TIP005365, D:VAL25 -: TIP005365,: TIP005365:C - C:LEU27,: TIP005365:C - C:VAL24,: TIP005365:C - C:LEU27,: TIP005365:C - B:LEU65,: TIP005365:C - C:VAL24, A:PHE26 -: TIP005365:C, B:PHE26 -: TIP005365:C, C:PHE23 -: TIP005365, C:PHE26 -: TIP005365:C,: TIP005365 - C:ALA22,: TIP005365 - D:ALA22 and: TIP005365 - D:VAL25) are formed. Hydrophobic bond length ranges from 3.81 Å to 5.31 Å (Figure 5(b)). Amino acid involved in the intermolecular interaction of Complex C with ligands, are ALA22, VAL25, PHE26, VAL29 and ILE33. Nine hydrophobic bonds (C:THR30:HG1 -: TIP003272:O,: TIP003272:H - D:ALA22:O, D:VAL25 -: TIP003272, D:VAL29 -: TIP003272,: TIP003272:C - D:VAL25,: TIP003272:C - D:VAL29,: TIP003272:C - C:ILE33, C:PHE23 - D:VAL25, D:PHE26 -: TIP003272:C,) are formed. Hydrophobic bond length ranges from 3.02 Å to 5.90 Å (Figure 5(c)). No hydrogen and electrostatic bonds is found in either of the three complexes.
Figure 5.

‘Three-dimensional’ representation of intermolecular interaction in (a) Complex A, (b) Complex B and (c) Complex C. Green, pink, orange, blue and cyan depicts chain A, B, C, D and E of the pentameric ‘SARS-CoV2 E’ protein, respectively. Dark brown depicts ligand.

‘Three-dimensional’ representation of intermolecular interaction in (a) Complex A, (b) Complex B and (c) Complex C. Green, pink, orange, blue and cyan depicts chain A, B, C, D and E of the pentameric ‘SARS-CoV2 E’ protein, respectively. Dark brown depicts ligand. In all the three complexes, amino acids present in the chain C and D mostly bind with ligands. Amino acids, namely VAL25 and PHE26 helps in bond formation in all three complexes. It is pertinent to note that these amino acids also experience the maximum RMSF during 200 ns simulation in the ‘SARS-CoV2 E’ protein; thereby suggesting their importance during protein-ligand interaction. Thus, in the near future, these amino acids present in the chain C and D of the ‘SARS-CoV2 E’ protein may serve as a biomarker for controlling pathogenesis caused via SARS-CoV2 in human.

Conclusion

In conclusion, the publically available structure of the humanSARS-CoV2 E’ protein was downloaded and employed to study its structure and function as well as its interaction with various phytochemicals using computational approaches. Results obtained revealed that the humanSARS-CoV2 E’ is a pentameric protein comprised of 35 α-helices and 40 loops. During 200 ns, α-helix and loops present in this protein experiences random movement, which in turn modulate normal ion channel activity; thereby aiding the pathogenesis caused via SARS-CoV2 in human and other vertebrates. However, after binding with Belachinal, Macaflavanone E, and Vibsanol B, the random motion of the humanSARS-CoV2 E’ protein gets reduced; this, in turn, inhibits the function of the humanSARS-CoV2 E’ protein. It is pertinent to note that, this is for the first time, authors are reporting about the medicinal property of Macaflavanone E, Vibsanol B. As these three phytochemicals, namely, Belachinal, Macaflavanone E & Vibsanol B, have passed the ADMET test and ‘Lipinski’s Rule of 5s’, they may be utilized in controlling disease caused via SARS-CoV2, in near future, after further in vitro and in vivo investigations.
  56 in total

1.  In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19.

Authors:  Rupesh V Chikhale; Saurabh K Sinha; Rajesh B Patil; Satyendra K Prasad; Anshul Shakya; Nilambari Gurav; Rupali Prasad; Suhas R Dhaswadikar; Manish Wanjari; Shailendra S Gurav
Journal:  J Biomol Struct Dyn       Date:  2020-06-24

2.  Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium.

Authors:  Aujan Mehregan; Sergio Pérez-Conesa; Yuxuan Zhuang; Ahmad Elbahnsi; Diletta Pasini; Erik Lindahl; Rebecca J Howard; Chris Ulens; Lucie Delemotte
Journal:  Biochim Biophys Acta Biomembr       Date:  2022-06-18       Impact factor: 4.019

3.  Identification of Cyanobacteria-Based Natural Inhibitors Against SARS-CoV-2 Druggable Target ACE2 Using Molecular Docking Study, ADME and Toxicity Analysis.

Authors:  Niharika Sahu; Sonal Mishra; Minu Kesheri; Swarna Kanchan; Rajeshwar P Sinha
Journal:  Indian J Clin Biochem       Date:  2022-07-05

Review 4.  Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.

Authors:  Rachana Singh; Pradhyumna Kumar Singh; Rajnish Kumar; Md Tanvir Kabir; Mohammad Amjad Kamal; Abdur Rauf; Ghadeer M Albadrani; Amany A Sayed; Shaker A Mousa; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

Review 5.  Flavonoids are promising safe therapy against COVID-19.

Authors:  Moza Mohamed Alzaabi; Rania Hamdy; Naglaa S Ashmawy; Alshaimaa M Hamoda; Fatemah Alkhayat; Neda Naser Khademi; Sara Mahmoud Abo Al Joud; Ali A El-Keblawy; Sameh S M Soliman
Journal:  Phytochem Rev       Date:  2021-05-22       Impact factor: 7.741

6.  Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection.

Authors:  Dennis C Copertino; Bruno C Casado Lima; Rodrigo R R Duarte; Timothy R Powell; Christopher E Ormsby; Timothy Wilkin; Roy M Gulick; Miguel de Mulder Rougvie; Douglas F Nixon
Journal:  J Biomol Struct Dyn       Date:  2021-03-18       Impact factor: 5.235

Review 7.  COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.

Authors:  Xueqing Wang; Yuanfang Guan
Journal:  Med Res Rev       Date:  2020-08-30       Impact factor: 12.944

8.  The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis.

Authors:  Krzysztof Marciniec; Artur Beberok; Stanisław Boryczka; Dorota Wrześniok
Journal:  Pharmacol Rep       Date:  2021-05-30       Impact factor: 3.024

9.  Phenolic compounds as promising drug candidates against COVID-19 - an integrated molecular docking and dynamics simulation study.

Authors:  Rakesh Davella; Swapna Gurrapu; Estari Mamidala
Journal:  Mater Today Proc       Date:  2021-05-31

10.  Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.

Authors:  Sajjad Ahmad; Yasir Waheed; Asma Abro; Sumra Wajid Abbasi; Saba Ismail
Journal:  J Mol Model       Date:  2021-06-24       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.